| Financial Year |
March 31 2023 |
| Monetary Funds |
249,546,369.14 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
244,889,134.78 |
| Advances to Suppliers |
39,910,047.73 |
| Other Receivables |
12,372,200.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
635,759,362.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,374,332.88 |
| Total Current Assets |
1,259,466,443.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
64,421,451.89 |
| Investment Properties |
-- |
| Fixed Assetes |
1,273,979,255.13 |
| Under-construction Projects |
319,689,501.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
169,865,758.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
8,810,429.66 |
| Other Non-Current Assets |
5,114,700.00 |
| Sub-Total of Non-Current Assets |
1,847,841,792.32 |
| Total Assets |
3,107,308,236.19 |
| Short-Term Loans |
568,696,686.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
208,515,856.28 |
| Accounts Payable |
269,461,395.28 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
17,711,311.82 |
| Taxes Payable |
15,912,691.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
57,612,556.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,051,352.45 |
| Other Current Liabilities |
574,520.82 |
| Sub-Total of Current Liabilities |
1,184,304,994.29 |
| Long-term Loans |
120,298,240.42 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
912,287.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
136,106,687.41 |
| Total Liabilities |
1,320,411,681.70 |
| Paid-In Capital(Or Share Stock) |
106,922,067.00 |
| Capital Surplus |
1,107,814,521.32 |
| Surplus Reserve |
87,727,115.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
430,416,848.48 |
| Minority Stockholder's Interest |
52,765,298.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,734,131,256.48 |
| Owner's Equity（Stockholder's Equity） |
1,786,896,554.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,107,308,236.19 |
